Ftse Mib
36.719,35
1,38%
DAX
21.505,70
0,47%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
98.101,00
0,25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Akero Therapeutics Inc (AKRO) Akero Therapeutics Inc (AKRO) Notizie

Akero Therapeutics Inc

AKRO
57,00
3,15 (5,85%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/1/202515:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202515:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:05GLOBEAkero Therapeutics Announces Closing of Upsized Public..
30/1/202513:52EDGAR2Form 8-K - Current report
30/1/202502:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202502:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202502:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202523:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/1/202503:30GLOBEAkero Therapeutics Announces Pricing of Upsized Public..
28/1/202503:35EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
28/1/202500:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202500:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/1/202522:24EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:24EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:23EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:19EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:06EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:01GLOBEAkero Therapeutics Announces Proposed Public Offering of..
27/1/202514:31EDGAR2Form 8-K - Current report
27/1/202512:30GLOBEAkero Therapeutics Reports Preliminary Topline Results..
24/1/202522:05GLOBEAkero Therapeutics to Present Preliminary Topline Week 96..
24/1/202517:01PRNUSKuehn Law Encourages Investors of Akero Therapeutics, Inc...
13/1/202513:00GLOBEAkero Therapeutics Completes Enrollment of the Double-Blind..
11/1/202501:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202513:00GLOBEAkero Therapeutics to Present at the 43rd Annual J.P. Morgan..
06/1/202520:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:29EDGAR2Form 144 - Report of proposed sale of securities
31/12/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:30EDGAR2Form 144 - Report of proposed sale of securities
13/12/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:25EDGAR2Form 144 - Report of proposed sale of securities
05/12/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202413:00GLOBEAkero Therapeutics to Present at the 7th Annual Evercore ISI..
20/11/202403:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202417:00GLOBEAkero Therapeutics to Showcase New Analyses of Phase 2b..
13/11/202422:05GLOBEAkero Therapeutics to Present at the Jefferies London..
08/11/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 53,60 Min: 53,60 Max: 57,25
Chiusura: 53,85

La tua Cronologia

NASDAQ
AKRO
Akero Therapeutics
NASDAQ
ABLQXXX
Barclays Bank Plc Autoca...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci